RORα has been reported as a potential tumor suppressor in solid tumors, including breast cancer, lung cancer, melanoma, colon cancer, hepatocellular carcinoma, prostate cancer, and glioma [6,10,11,12,13,14,15]. Here, RORA is linked to breast cancer.